Erste Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.04M | Hold |
51,300
| – | – | 0.02% | 393 |
|
|
2025
Q1 | $1.6M | Hold |
51,300
| – | – | 0.02% | 329 |
|
|
2024
Q4 | $1.84M | Hold |
51,300
| – | – | 0.02% | 336 |
|
|
2024
Q3 | $2.1M | Hold |
51,300
| – | – | 0.03% | 316 |
|
|
2024
Q2 | $2.42M | Hold |
51,300
| – | – | 0.03% | 291 |
|
|
2024
Q1 | $2.29M | Hold |
51,300
| – | – | 0.03% | 290 |
|
|
2023
Q4 | $2.59M | Hold |
51,300
| – | – | 0.04% | 272 |
|
|
2023
Q3 | $2.37M | Hold |
51,300
| – | – | 0.04% | 258 |
|
|
2023
Q2 | $2.11M | Hold |
51,300
| – | – | 0.04% | 284 |
|
|
2023
Q1 | $1.79M | Hold |
51,300
| – | – | 0.03% | 288 |
|
|
2022
Q4 | $1.92M | Hold |
51,300
| – | – | 0.04% | 280 |
|
|
2022
Q3 | $2.27M | Hold |
51,300
| – | – | 0.05% | 272 |
|
|
2022
Q2 | $1.93M | Hold |
51,300
| – | – | 0.04% | 285 |
|
|
2022
Q1 | $1.83M | Hold |
51,300
| – | – | 0.03% | 305 |
|
|
2021
Q4 | $1.57M | Hold |
51,300
| – | – | 0.03% | 320 |
|
|
2021
Q3 | $1.72M | Hold |
51,300
| – | – | 0.03% | 287 |
|
|
2021
Q2 | $2.03M | Buy |
51,300
+16,800
| +49% | +$664K | 0.04% | 279 |
|
|
2021
Q1 | $1.54M | Sell |
34,500
-17,000
| -33% | -$760K | 0.04% | 300 |
|
|
2020
Q4 | $2.94M | Sell |
51,500
-6,500
| -11% | -$371K | 0.08% | 227 |
|
|
2020
Q3 | $2.81M | Sell |
58,000
-2,660
| -4% | -$129K | 0.1% | 208 |
|
|
2020
Q2 | $3.6M | Sell |
60,660
-1,470
| -2% | -$87.3K | 0.14% | 159 |
|
|
2020
Q1 | $2.99M | Sell |
62,130
-4,116
| -6% | -$198K | 0.17% | 147 |
|
|
2019
Q4 | $4.02M | Buy |
66,246
+3,046
| +5% | +$185K | 0.18% | 131 |
|
|
2019
Q3 | $3.73M | Hold |
63,200
| – | – | 0.2% | 127 |
|
|
2019
Q2 | $4.09M | Buy |
63,200
+15,200
| +32% | +$983K | 0.22% | 118 |
|
|
2019
Q1 | $3.83M | Buy |
+48,000
| New | +$3.83M | 0.21% | 114 |
|